BackProtagonist Therapeutics Overview

Protagonist Therapeutics Profit Margin

Profitability ratio analysis for PTGX.

Quarterly Profit Margin

6.71%
↑ 116.31% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-644.84%
↓ 2484.62% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin